An Exploratory Immune‐Associated Prognostic Signature and AREG‐Associated Phenotypes in Oral Squamous Cell Carcinoma
The International Journal of Medical Robotics and Computer Assisted Surgery · 2026
DOI: 10.1002/rcs.70237 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Medical Robotics and Computer Assisted Surgery, 2026. Verfasst von Shiling Dong und 3 weiteren Autor:innen. Beteiligte Einrichtung: School and Hospital of Stomatology, Dental Implant Center, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Amphiregulin, Mouth Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Background
Oral squamous cell carcinoma (OSCC) remains a clinically heterogeneous malignancy with unsatisfactory long‐term outcomes, particularly in patients with advanced disease and treatment resistance. Conventional clinicopathologic parameters incompletely capture the biological diversity of OSCC and provide limited guidance for individualised therapeutic stratification.
Methods
We performed an integrated transcriptomic analysis of TCGA‐derived OSCC data to construct and evaluate an immune‐associated prognostic signature. Associations with survival, clinicopathologic features, immune infiltration, somatic mutation profiles and pathway‐level biological programs were assessed. The manuscript‐specified ten‐gene equation was additionally evaluated without refitting in an independent CPTAC oral‐cavity SCC cohort using overall survival, Harrell's C‐index and time‐dependent ROC analysis. Amphiregulin (AREG) was selected for functional investigation using siRNA‐mediated knockdown, proliferation assays, cisplatin sensitivity testing, IC50 estimation and apoptosis analysis in OSCC cells.
Results
The original TCGA analysis separated survival groups and reported 1‐, 3‐ and 5‐year AUCs of 0.701, 0.693 and 0.623. In 42 independent CPTAC patients with 14 deaths, however, the fixed score was not significantly associated with overall survival (HR per SD, 1.181; 95% CI, 0.674–2.069; p = 0.561). The C‐index was 0.521, and the 1‐ and 3‐year AUCs were 0.369 and 0.550; 5‐year evaluation was unsupported by follow‐up. The supplied AREG experiments suggested reduced proliferation and increased cisplatin sensitivity after knockdown.
Conclusions
This study identifies an exploratory immune‐associated score and AREG‐associated cellular phenotypes in OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School and Hospital of Stomatology, Dental Implant Center, Wenzhou Medical University, Wenzhou, China.
- School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, China.
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Affiliated Hospital of Medical School, Nanjing Stomatological Hospital, Institute of Stomatology, Nanjing University, Nanjing, China.
ORCID-Profile: Shiling Dong, Guangwen Yang
Zitieren
APA
Dong, S., Cheng, J., Xing, S., & Yang, G. (2026). An Exploratory Immune‐Associated Prognostic Signature and AREG‐Associated Phenotypes in Oral Squamous Cell Carcinoma. The International Journal of Medical Robotics and Computer Assisted Surgery. https://doi.org/10.1002/rcs.70237
Vancouver
Dong S, Cheng J, Xing S, Yang G. An Exploratory Immune‐Associated Prognostic Signature and AREG‐Associated Phenotypes in Oral Squamous Cell Carcinoma. The International Journal of Medical Robotics and Computer Assisted Surgery. 2026. doi:10.1002/rcs.70237
BibTeX
@article{Dong2026,
author = {Dong, Shiling and Cheng, Jingjing and Xing, Shuanfeng and Yang, Guangwen},
title = {An Exploratory Immune‐Associated Prognostic Signature and AREG‐Associated Phenotypes in Oral Squamous Cell Carcinoma},
journal = {The International Journal of Medical Robotics and Computer Assisted Surgery},
year = {2026},
doi = {10.1002/rcs.70237}
}
EUVIMED